Back to search

Article

Small molecule FICD inhibitors suppress endogenous and pathologic FICD-mediated protein AMPylation

2024-07-16

Abstract excerpt

<h4>Summary</h4> The AMP transferase, FICD, is an emerging drug target finetuning stress signaling in the endoplasmic reticulum (ER). FICD is a bi-functional enzyme, catalyzing both AMP addition (AMPylation) and removal (deAMPylation) from the ER resident chaperone BiP/GRP78. Despite increasing evidence linking excessive BiP/GRP78 AMPylation to human diseases, small molecules to inhibit pathogenic FICD variants a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
86cf115c-ea5a-5044-a6dd-c9fcb78fc6dc
DOI
10.1101/2024.07.13.603377
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Small molecule FICD inhibitors suppress endogenous and pathologic FICD-mediated protein AMPylationDOI 10.1101/2024.07.13.603377
Select a neighboring publication to make it the new centre.